Literature DB >> 19203218

Embryonic stem cells in cardiac repair and regeneration.

Dinender K Singla1.   

Abstract

Cell transplantation is a subject of fast-growing research with a potential of a therapeutic approach for the treatment of heart diseases. Clinical applications require preparation of large number of donor cells. Stem cell studies published to date demonstrate that scientists have not reached the general consensus to use an optimal cell type for better cardiac repair and regeneration. We used embryonic stem (ES) cells and their released factors for cardiac repair and regeneration. The major concern of cardiac regeneration with stem cells includes engraftment, differentiation, and teratoma formation after ES cell transplantation. Our current knowledge of ES cell transplantation in the heart is very limited. This review discusses the use of various growth factors to enhance ES cells engraftment and differentiation, as well as the issue of teratoma formation.

Entities:  

Mesh:

Year:  2009        PMID: 19203218      PMCID: PMC2788053          DOI: 10.1089/ars.2009.2491

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  63 in total

1.  Prevention by anti-LFA-1 of acute myoblast death following transplantation.

Authors:  B Guérette; D Skuk; F Célestin; C Huard; F Tardif; I Asselin; B Roy; M Goulet; R Roy; M Entman; J P Tremblay
Journal:  J Immunol       Date:  1997-09-01       Impact factor: 5.422

Review 2.  Myocyte cell death and ventricular remodeling.

Authors:  P Anversa; G Olivetti; A Leri; Y Liu; J Kajstura
Journal:  Curr Opin Nephrol Hypertens       Date:  1997-03       Impact factor: 2.894

3.  Stem cell differentiation requires a paracrine pathway in the heart.

Authors:  Atta Behfar; Leonid V Zingman; Denice M Hodgson; Jean-Michel Rauzier; Garvan C Kane; Andre Terzic; Michel Pucéat
Journal:  FASEB J       Date:  2002-10       Impact factor: 5.191

4.  Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial.

Authors:  Volker Schächinger; Birgit Assmus; Martina B Britten; Jörg Honold; Ralf Lehmann; Claudius Teupe; Nasreddin D Abolmaali; Thomas J Vogl; Wolf-Karsten Hofmann; Hans Martin; Stefanie Dimmeler; Andreas M Zeiher
Journal:  J Am Coll Cardiol       Date:  2004-10-19       Impact factor: 24.094

5.  Both apoptosis and necrosis occur early after intracerebral grafting of ventral mesencephalic tissue: a role for protease activation.

Authors:  M Emgård; U Hallin; J Karlsson; B A Bahr; P Brundin; K Blomgren
Journal:  J Neurochem       Date:  2003-09       Impact factor: 5.372

6.  Caspase inhibition reduces apoptosis and increases survival of nigral transplants.

Authors:  G S Schierle; O Hansson; M Leist; P Nicotera; H Widner; P Brundin
Journal:  Nat Med       Date:  1999-01       Impact factor: 53.440

7.  Stable benefit of embryonic stem cell therapy in myocardial infarction.

Authors:  Denice M Hodgson; Atta Behfar; Leonid V Zingman; Garvan C Kane; Carmen Perez-Terzic; Alexey E Alekseev; Michel Pucéat; Andre Terzic
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-08       Impact factor: 4.733

8.  Embryonic stem cell lines derived from human blastocysts.

Authors:  J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

Review 9.  Remodeling of the myocardium and potential targets in the collagen degradation and synthesis pathways.

Authors:  Bodh I Jugdutt
Journal:  Curr Drug Targets Cardiovasc Haematol Disord       Date:  2003-03

10.  Role of interleukin-1beta in acute inflammation and graft death after cell transplantation to the heart.

Authors:  Ken Suzuki; Bari Murtuza; Jonathan R Beauchamp; Nigel J Brand; Paul J R Barton; Anabel Varela-Carver; Satsuki Fukushima; Steven R Coppen; Terence A Partridge; Magdi H Yacoub
Journal:  Circulation       Date:  2004-09-14       Impact factor: 29.690

View more
  13 in total

Review 1.  De novo myocardial regeneration: advances and pitfalls.

Authors:  Khawaja Husnain Haider; Stephanie Buccini; Rafeeq P H Ahmed; Muhammad Ashraf
Journal:  Antioxid Redox Signal       Date:  2010-10-12       Impact factor: 8.401

Review 2.  Stem cells in the infarcted heart.

Authors:  Dinender K Singla
Journal:  J Cardiovasc Transl Res       Date:  2009-11-20       Impact factor: 4.132

Review 3.  The Role of the Microenvironment in Controlling the Fate of Bioprinted Stem Cells.

Authors:  Lauren N West-Livingston; Jihoon Park; Sang Jin Lee; Anthony Atala; James J Yoo
Journal:  Chem Rev       Date:  2020-06-19       Impact factor: 60.622

4.  Icariin induces mouse embryonic stem cell differentiation into beating functional cardiomyocytes.

Authors:  Xiaodong Sun; Xiuwei Sun; Xiudong Jin; Xiaoli Zhang; Chunling Liu; Lei Lei; Lianhong Jin; Huiwen Liu
Journal:  Mol Cell Biochem       Date:  2010-12-23       Impact factor: 3.396

5.  Factors Released from Embryonic Stem Cells Stimulate c-kit-FLK-1(+ve) Progenitor Cells and Enhance Neovascularization.

Authors:  Sumbul Fatma; Donald E Selby; Reetu D Singla; Dinender K Singla
Journal:  Antioxid Redox Signal       Date:  2010-07-28       Impact factor: 8.401

6.  Embryonic stem cells improve cardiac function in Doxorubicin-induced cardiomyopathy mediated through multiple mechanisms.

Authors:  Dinender K Singla; Aisha Ahmed; Reetu Singla; Binbin Yan
Journal:  Cell Transplant       Date:  2012-03-22       Impact factor: 4.064

7.  Reprogramming of skeletal myoblasts for induction of pluripotency for tumor-free cardiomyogenesis in the infarcted heart.

Authors:  Rafeeq P H Ahmed; Husnain K Haider; Stephanie Buccini; Longhu Li; Shujia Jiang; Muhammad Ashraf
Journal:  Circ Res       Date:  2011-05-12       Impact factor: 17.367

Review 8.  Preconditioning and stem cell survival.

Authors:  Husnain Kh Haider; Muhammad Ashraf
Journal:  J Cardiovasc Transl Res       Date:  2009-12-22       Impact factor: 4.132

9.  TGF-β2 treatment enhances cytoprotective factors released from embryonic stem cells and inhibits apoptosis in infarcted myocardium.

Authors:  Dinender K Singla; Reetu D Singla; Stephanie Lamm; Carley Glass
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-02-04       Impact factor: 4.733

10.  Notch-1 mediated cardiac protection following embryonic and induced pluripotent stem cell transplantation in doxorubicin-induced heart failure.

Authors:  Hilda Merino; Dinender K Singla
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.